/Companies

Verdiva Bio

77 employees on LinkedIn · 4 known investors

Find your way into Verdiva Bio

Sign up to see every warm intro you have to Verdiva Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Verdiva Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Verdiva Bio is a biotechnology company focused on drug development. Its leadership brings experience in in-licensing, commercialization, and business development across the international biotech industry.

Founders & leadership

JHJane Hughes
Jane HughesChief Scientific OfficerChief Scientific Officer of Verdiva Bio, Jane Hughes has expertise in drug development, translational research, and scientific domains including immunology, inflammation, neuroscience, and cell biology.
KFKhurem Farooq
Khurem FarooqFounder

Investors · 4

Funding

SEC filings, press & company announcements

$410M disclosed across 1 round · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Verdiva Bio do?
Verdiva Bio is a biotechnology company focused on drug development. Its leadership brings experience in in-licensing, commercialization, and business development across the international biotech industry.
Who are Verdiva Bio's investors?
Verdiva Bio's investors include General Atlantic, OrbiMed, RA Capital, Forbion.
How much funding has Verdiva Bio raised?
Verdiva Bio has disclosed $410M raised across 1 round.